[1] Wilson DM 3rd, Cookson MR, Van Den Bosch L, et al. Hallmarks of neurodegenerative diseases[J]. Cell, 2023, 186(4): 693-714. [2] Rahul, Siddique YH.Neurodegenerative Diseases and Flavonoids: Special Reference to Kaempferol[J]. CNS Neurol Disord Drug Targets, 2021, 20(4): 327-342. [3] Sharoar MG, Thapa A, Shahnawaz M, et al.Keampferol-3-O-rhamnoside abrogates amyloid beta toxicity by modulating monomers and remodeling oligomers and fibrils to non-toxic aggregates[J]. J Biomed Sci, 2012, 19(1): 104. [4] Park SE, Sapkota K, Kim S, et al.Kaempferol acts through mitogen-activated protein kinases and protein kinase B/AKT to elicit protection in a model of neuroinflammation in BV2 microglial cells[J]. Br J Pharmacol, 2011, 164(3): 1008-1025. [5] Rosa E, Fahnestock M.CREB expression mediates amyloid β-induced basal BDNF downregulation[J]. Neurobiol Aging, 2015, 36(8): 2406-2413. [6] Jantas D, Malarz J, Le TN, et al.Neuroprotective Properties of Kempferol Derivatives from Maesa membranacea against Oxidative Stress-Induced Cell Damage: An Association with Cathepsin D Inhibition and PI3K/Akt Activation[J]. Int J Mol Sci, 2021, 22(19): 10363. [7] Zhang S, Lu Y, Chen W, et al.Network Pharmacology and Experimental Evidence: PI3K/AKT Signaling Pathway is Involved in the Antidepressive Roles of Chaihu Shugan San[J]. Drug Des Devel Ther, 2021, 15: 3425-3441. [8] Can MV, Tran AH, Pham DM, et al.Willughbeia cochinchinensis prevents scopolamine-induced deficits in memory, spatial learning, and object recognition in rodents[J]. J Ethnopharmacol, 2018, 214: 99-105. [9] Hori Y, Watanabe K, Yassen ASA, et al.Enhancement of Neprilysin Activity by Natural Polyphenolic Compounds and Their Derivatives in Cultured Neuroglioma Cells[J]. Biol Pharm Bull, 2023, 46(3): 446-454. [10] Moore K, Sengupta U, Puangmalai N, et al.Polymorphic Alpha-Synuclein Oligomers: Characterization and Differential Detection with Novel Corresponding Antibodies[J]. Mol Neurobiol, 2023, 60(5): 2691-2705. [11] Rahul, Naz F, Jyoti S, et al. Effect of kaempferol on the transgenic Drosophila model of Parkinson's disease[J]. Sci Rep, 2020, 10(1): 13793. [12] 刘展,蔡美云,庄文欣,等. 山柰酚通过mTOR通路诱导细胞自噬保护帕金森病模型小鼠多巴胺能神经元[J]. 中药新药与临床药理,2022,33(04):446-453. [13] Han X, Sun S, Sun Y, et al.Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease[J]. Autophagy, 2019, 15(11): 1860-1881. [14] Filomeni G, Graziani I, De Zio D, et al.Neuroprotection of kaempferol by autophagy in models of rotenone-mediated acute toxicity: possible implications for Parkinson's disease[J]. Neurobiol Aging, 2012, 33(4): 767-785. [15] Liu YY, Yu LH, Zhang J, et al.Network Pharmacology-Based and Molecular Docking-Based Analysis of Suanzaoren Decoction for the Treatment of Parkinson's Disease with Sleep Disorder[J]. Biomed Res Int, 2021, 2021: 1752570. [16] Johnson EB, Gregory S.Huntington's disease: Brain imaging in Huntington's disease[J]. Prog Mol Biol Transl Sci, 2019, 165: 321-369. [17] Kang B, Wang X, Xu Q, et al. Effect of 3-nitropropionic acid inducing oxidative stress and apoptosis of granulosa cells in geese[J]. Biosci Rep, 2018, 38(5): BSR20180274. [18] Liddelow SA, Guttenplan KA, Clarke LE, et al.Neurotoxic reactive astrocytes are induced by activated microglia[J]. Nature, 2017, 541(7638): 481-487. [19] Lopez-Sanchez C, Poejo J, Garcia-Lopez V, et al . Kaempferol prevents the activation of complement C3 protein and the generation of reactive A1 astrocytes that mediate rat brain degeneration induced by 3-nitropropionic acid[J]. Food Chem Toxicol, 2022, 164: 113017. [20] Lagoa R, Lopez-Sanchez C, Samhan-Arias AK, et al.Kaempferol protects against rat striatal degeneration induced by 3-nitropropionic acid[J]. J Neurochem, 2009, 111(2): 473-487. [21] van den Bos MAJ, Geevasinga N, Higashihara M, et al. Pathophysiology and Diagnosis of ALS: Insights from Advances in Neurophysiological Techniques[J]. Int J Mol Sci, 2019, 20(11): 2818. [22] Nourelden AZ, Kamal I, Hagrass AI, et al.Safety and efficacy of edaravone in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis[J]. Neurol Sci, 2023, 44(10): 3429-3442. [23] Srinivasan E, Rajasekaran R.Comparative binding of kaempferol and kaempferide on inhibiting the aggregate formation of mutant (G85R) SOD1 protein in familial amyotrophic lateral sclerosis: A quantum chemical and molecular mechanics study[J]. Biofactors, 2018, 44(5): 431-442. [24] Ueda T, Inden M, Shirai K, et al.The effects of Brazilian green propolis that contains flavonols against mutant copper-zinc superoxide dismutase-mediated toxicity[J]. Sci Rep, 2017, 7(1): 2882. [25] Kumar S, Kim YR, Vikram A, et al.Sirtuin1-regulated lysine acetylation of p66Shc governs diabetes-induced vascular oxidative stress and endothelial dysfunction[J]. Proc Natl Acad Sci USA, 2017, 114(7): 1714-1719. [26] Zhou YP, Li GC.Kaempferol Protects Cell Damage in In Vitro Ischemia Reperfusion Model in Rat Neuronal PC12 Cells[J]. Biomed Res Int, 2020, 2020: 2461079. [27] Zhang SS, Liu M, Liu DN, et al.Network Pharmacology Analysis and Experimental Validation of Kaempferol in the Treatment of Ischemic Stroke by Inhibiting Apoptosis and Regulating Neuroinflammation Involving Neutrophils[J]. Int J Mol Sci, 2022, 23(20): 12694. |